Skip to content

Clinical trials

Phase 3 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 3 Clear all

223 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20038
200412
200510
200613
200710
20086
20099
20104
20113
20128
20131
20141
20159
201614
20179
20187
201916
202013
202113
202216
20238
20246
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed167
Recruiting13
Withdrawn12
Unknown status12
Terminated8
Active, not recruiting4
Not yet recruiting4
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer16
GlaxoSmithKline13
Organon and Co13
Allergan12
AbbVie10
Eli Lilly and Company9
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.9
H. Lundbeck A/S6
Kafrelsheikh University6
Teva Branded Pharmaceutical Products R&D, Inc.6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders223
Headache54
Migraine without Aura12
Migraine with Aura11
Epilepsy8
Photophobia6
Bronchiolitis Obliterans Syndrome5
Foramen Ovale, Patent5
Headache Disorders5
Hyperacusis5

Trials

Showing 51 to 75 of 223. Each trial links to its page on Pharma Observatory.

123 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.